Since the last CCSG review, AECC has undertaken an intensive and ongoing process of planning and evaluation. Intrinsic to this process vi/as: (i) the AECC Steering Committees consisting of all program leaders, Executive Committee members, leaders of the major clinical oncology services, and other key College and AECC faculty and (ii) The External Scientific Advisory Committee (ESAC) which consists of eleven members with expertise relevant to AECC research programs and their administration. In addition, ad hoc members were included at ESAC meetings to provide special expertise in guiding the implementation of a developing Cancer Prevention and Control program. In June 2008, there was a major planning retreat that culminated in the formulation of a Strategic Plan. The overarching strategic objectives that emerged at this retreat were to improve AECC's structure to optimally harness the strong basic science elements in AECC programs in order to enhance clinical/translational research, to strengthen the clinical research enterprise, and to expand population research which, collectively, would enhance the comprehensive nature of this center ultimately leading to comprehensive designation. Major programmatic goals that emerged from the June 2008 retreat were: (i) to strengthen the clinical oncology services at MMC with the recruitment of a cadre of committed clinician/researchers, (ii) to create the position of Associate Director for Clinical Services at MMC in order to establish a multidisciplinary clinical structure at MMC that encompasses all the oncology and support services, (iii) to review the AECC programmatic structure in order to identify ways to enhance its disease focus and translational capabilities, and to (iv) build behavioral sciences with the objective of ultimately establishing a Cancer Prevention and Control Program. Intrinsic to the plan was strengthening and broadening the scope of basic research at the Center leveraging College and AECC resources. Another important element in the Planning and Evaluation process was the annual off-campus """"""""Advances"""""""" meeting when the scientific thrust and collaborations among working groups and individual investigators, and their integration into the programmatic structure of the Center, could be evaluated and new needed research areas and technologies identified. Developments Funds were targeted based upon needs identified within the context of the Planning and Evaluation process. Support is requested for travel and consultation fees for external advisors and for the annual """"""""Advances"""""""" off-campus retreat of the entire AECC membership and for planning retreats of the AECC leadership.

Public Health Relevance

Planning and evaluation funds support both external and internal advisory and evaluation activities centered the development of our scientific activities in support of the translational research mission and goals of the Albert Einstein Cancer Center (AECC). As an NCI-designated Cancer Center, AECC contributes to the national effort to reduce morbidity and mortality from cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
United States
Zip Code
Jerschow, Elina; Strizich, Garrett; Xue, Xiaonan et al. (2017) Effect of Relocation to the U.S. on Asthma Risk Among Hispanics. Am J Prev Med 52:579-588
Zhao, H; Lu, Z; Bauzon, F et al. (2017) p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer. Oncogene 36:60-70
Saied-Santiago, Kristian; Townley, Robert A; Attonito, John D et al. (2017) Coordination of Heparan Sulfate Proteoglycans with Wnt Signaling To Control Cellular Migrations and Positioning in Caenorhabditis elegans. Genetics 206:1951-1967
Mirabello, Lisa; Yeager, Meredith; Yu, Kai et al. (2017) HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell 170:1164-1174.e6
Miller, Eirwen M; Patterson, Nicole E; Zechmeister, Jenna Marcus et al. (2017) Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants. Oncotarget 8:102033-102045
Zhao, Dejian; Mokhtari, Ryan; Pedrosa, Erika et al. (2017) Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress. Mol Autism 8:17
Miskolci, Veronika; Hodgson, Louis; Cox, Dianne (2017) Using Fluorescence Resonance Energy Transfer-Based Biosensors to Probe Rho GTPase Activation During Phagocytosis. Methods Mol Biol 1519:125-143
Kunnath-Velayudhan, Shajo; Goldberg, Michael F; Saini, Neeraj K et al. (2017) Transcriptome Analysis of Mycobacteria-Specific CD4+ T Cells Identified by Activation-Induced Expression of CD154. J Immunol 199:2596-2606
Tevaarwerk, Amye J; Hocking, William G; Zeal, Jamie L et al. (2017) Accuracy and Thoroughness of Treatment Summaries Provided as Part of Survivorship Care Plans Prepared by Two Cancer Centers. J Oncol Pract 13:e486-e495
Harney, Allison S; Karagiannis, George S; Pignatelli, Jeanine et al. (2017) The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors. Mol Cancer Ther 16:2486-2501

Showing the most recent 10 out of 1417 publications